Inogen | INGN - Loan Capital


Inogen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.42M 148.07M Jun/2026
AtriCure USD 61M 0 Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 0 Jun/2026
Medtronic USD 27.88B 255M Dec/2025
Orthofix International USD 221.59M 256K Jun/2026
Philips EUR 6.32B 575M Jun/2026
ResMed USD 399.42M 4.75M Jun/2026
Steris USD 1.65B 162.6M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
X T L Biopharmaceuticals USD 0 0 Dec/2024
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026